Health Canada OK's non-prescription nasal spray overdose antidote

Health Canada has authorized non-prescription use of naloxone nasal spray to temporarily reverse opioid overdoses.

Needle-free nasal spray easier to administer

The nasal spray version of naloxone was developed by Adapt Pharma, a Dublin-based company that markets the product under the brand name Narcan. (Adapt Pharma)

Canadians will now be able to acquire naloxone nasal spray without a prescription, Health Canada says.

Health Minister Jane Philpott authorized the nasal spray, which works to temporarily reverse a potentially fatal opioid overdose, after an expedited review, the department said in a release on Monday.

The needle-free nasal spray is easy to administer and ensures that anyone can reverse an opioid overdose and save lives within a few minutes, said Dublin-based Adapt Pharma. The company intends to market the product in Canada. 

Health Canada said more information on when the newly approved product will be available will be provided "in the near future."

Health Canada says the nasal spray's manufacturer can now take the steps needed to officially bring the product to market in Canada. Until then, the U.S.-approved product will continue to be available in Canada to avoid interruption in supply.

The interim order called the authorization "an emergency public health measure in response to the current opioid crisis."

With files from The Canadian Press

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.